https://pkc-inhibitors.com/ind....ex.php/reversibility
At few days 24 dCBT, when compared with SHE, also reduced use of prescription and non-prescription sleep medicine as much as week 24 (modified price proportion [RR] 0.64, 95% CI 0.42; 0.97, p = .037 and adjusted RR 0.52, 95% CI 0.37; 0.74, p less then .0001, respectively), but not healthcare utilization. Uncontrolled follow-up suggests that these effects were sustained for non-prescribed sleep medication (RR 0.52, 95% CI 0.40; 0.67, p less